Stryker is a medical device company located in Michigan, United States, which is part of the Healthcare sector, and is traded under the ticker SYK on the NYSE exchange.
Stryker stock last closed at $380.23, up 2.03% from the previous day, and has decreased 1.6% in one year. It has overperformed other stocks in the Medical Devices industry by 0.77 percentage points. Stryker stock is currently +15.51% from its 52-week low of $329.16, and -6.09% from its 52-week high of $404.87.
As of Feb 20, 2026, there are 382.69M SYK shares outstanding. The market value of SYK is $145.51B. In the past 24 hours, 1.81M SYK shares were traded.
You need an online brokerage account in order to access the NYSE market and buy SYK stock.
Based on our experience, eToro is the best online stock brokerage. Here's why:
Get $10 towards your purchase of shares by opening an account with eToro now. This offer is only for US users.
Open eToro AccountNow that you've picked your brokerage, the next step is to fill out some personal info so you are able to buy SYK stock today.
Now that you have finished signing up on one of the best stock trading apps, you need to deposit funds:
Check out the walkthrough below if you need help transferring funds into your new brokerage account.
Once you have chosen the best place to buy Stryker stock, it's important to evaluate their stock prior to buying, so you can comprehend the risk as well as the opportunity.
WallStreetZen was created to help part-time investors perform more in-depth fundamental analysis in less time.
You can see all of the due diligence checks on SYK's stock page.
Analysts use a variety of different financial metrics, analyses, models, and charts to gauge SYK's true value.
Using relative valuations ratios:
You can do additional valuation analysis on SYK's stock here.
Out of 10 sell side analysts who track SYK, the consensus analyst rating on Stryker is a Buy
Please keep in mind that analyst ratings are not stock recommendations, nor are they financial advice.
Joanne Wuensch, a top 7% analyst from Citigroup maintains SYK with a strong buy rating and lowers their SYK price target from $455.00 to $420.00, on Dec 11, 2025.
Larry Biegelsen, a top 16% analyst from Wells Fargo maintains SYK with a strong buy rating and raises their SYK price target from $452.00 to $456.00, on Nov 14, 2025.
Wells Fargo's Larry Biegelsen raised their price target on Stryker (NYSE: SYK) by 0.9% from $452 to $456 on 2025/11/14. The analyst maintained their Strong Buy rating on the stock.
Stryker reported its Q3 2025 earnings on 2025/10/30.
Biegelsen attributed their price target hike to takeaways from investor meetings they hosted with company management.
The analyst told readers that the presentation highlighted the potential for sustained 10% organic revenue growth and double-digit EPS growth.
The 150 bps margin target for the next 3 years was slightly better than expected, Biegelsen continued.
Looking ahead, the analyst said that "key pipeline updates include the Mako RPS hand-held robot."
Vijay Kumar, a bottom 9% analyst from Evercore ISI Group maintains SYK with a buy rating and lowers their SYK price target from $410.00 to $405.00, on Oct 31, 2025.
Matt Miksic, a bottom 7% analyst from Barclays maintains SYK with a strong buy rating and raises their SYK price target from $443.00 to $453.00, on Oct 22, 2025.
Ed Ridley-Day, a bottom 22% analyst from Rothschild & Co initiates coverage on SYK with a hold rating and announces their SYK price target of $420.00, on Sep 18, 2025.
You can dig deeper into what analysts are forecasting on the Stryker stock forecast page.
Last year, SYK earnings were $3.25B. During the past 5 year, SYK's earnings have gone up by 14.79% per year. This was faster than the Medical Devices industry average of 14.48%.
Last year, SYK revenue was $25.12B. In the past five year, SYK's revenue has increased by 11.84% per year. This was faster than the Medical Devices industry average of 10.67%.
Find out more about SYK's earnings and revenue performance here.
In the last year, insiders at SYK have sold more shares than they have bought.
Kevin Lobo, Chair and CEO of SYK, was the latest SYK insider to buy. They bought $20,000,131.20 worth of SYK shares on Feb 6, 2026.
Research more about who owns SYK shares here.
Stryker pays a dividend of 0.89%, compared to the Medical Devices industry's average dividend yield of 1.12%. If you owned $1,000 worth of SYK stock, you would have been paid $8.94 last year.
Stryker dividend payments have consistently grown over the past decade and have remained stable.
Dig into more info about Stryker dividend yield and history here.
One of the major reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to learn what other traders have to say.
You have two main options:
Press the Open button and your broker will place your order.
If you require more help with investing in stocks on eToro, click the helpful video below:
Now that you own some SYK stock, you'll want to keep up with your new stock purchase.
Put SYK on a watchlist to track your SYK stock.
To summarize, here are the 6 steps to buy Stryker stock:
If you require a place to buy stocks, eToro is our recommended option.
Get Started with eToro TodayIf you want to keep track of your investment in Stryker, click the button below.